A message from our founders
Marieke and Wim de Niet, founders of Hycult Biotech
The time was 1994, a very eventful year. In previous years I had gained some experience with antibodies as director and owner of Sanbio B.V., by being at the cradle of the phenomenon that universities were interested in commercializing their “intellectual properties”, antibodies they had developed in their research.
Prof. Wim Buurman (University Maastricht) with whom I had a close contact and who already stood beside me during the early years, was a great help in acquiring Holland Biotechnology established in Leiden. The company in Leiden had done its best to build their business, but due to their intense research activities, they did not succeed in establishing a worldwide distribution network. The Netherlands alone was too limited as a market for their specialized products.
Worldwide outlets
At Sanbio, I set up a distribution network that allowed us to have worldwide outlets. In 1994 the decision was made for me to take over the company and rename it from Holland to Hycult (Hybridoma culture) Biotechnology. In the beginning weeks came and went with one or two orders for the antibodies. Through sheer will and perseverance more orders came, in part due to dedication of fantastic employees in the research and production. Without the team of people I would never have been able to fulfil the expectations of the business.
Ronald de Niet, CEO of Biocult
Our son, Ronald de Niet, became CEO of Hycult Biotechnology B.V in 2014. In 2019, Biocult became part of Hycult Biotechnology B.V., expanding its capabilities in development and manufacturing services. Operating under an EN ISO 13485:2016 certified quality management system, Biocult is committed to delivering products and services that meet the highest quality standards.
With a background in business administration and a strong commercial mindset, Ronald has played a key role in positioning Biocult as a trusted partner for researchers and life science organizations worldwide. By combining scientific expertise with a customer-focused approach, the company supports its customers with customized solutions in development and manufacturing.
After many rewarding years as CEO, Ronald has decided to step back from his day-to-day operational responsibilities. Following a period of personal reflection, he chose to create more time for the things that matter most to him, while remaining closely connected to the company. Ronald is not leaving Biocult. As he passes the leadership baton to Marja van Genugten, he will continue to be actively involved in the organization, sharing his expertise and remaining a familiar face for colleagues, customers, and partners.
Today, Biocult combines more than 30 years of expertise from both Biocult and Hycult Biotech. Our mission is to accelerate scientific discovery by delivering reliable products and services that contribute to a better understanding, monitoring, and treatment of disease, with particular expertise in innate immunity and the complement system.
Whether you require support with assay development, process optimization, pilot production, or large-scale manufacturing, Biocult has the expertise and capabilities to deliver tailored solutions that ensure the quality, consistency, and reliability your research and products depend on.
A fully streamlined laboratory
Now, almost 30 years later, we can be proud of what we have achieved. A fully streamlined laboratory and a highly skilled team of employees who carry the whole in their hands. TO BE PROUD OF, and I am indeed
